Chongqing Zhifei Biological Products Co., Ltd.

SZSE:300122 Stock Report

Market Cap: CN¥46.8b

Chongqing Zhifei Biological Products Management

Management criteria checks 3/4

Chongqing Zhifei Biological Products' CEO is Lingfeng Jiang, appointed in Sep 2024, has a tenure of less than a year. directly owns 5.41% of the company’s shares, worth CN¥2.53B. The average tenure of the management team and the board of directors is 0.7 years and 7.4 years respectively.

Key information

Lingfeng Jiang

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership5.4%
Management average tenureless than a year
Board average tenure7.4yrs

Recent management updates

Recent updates

Investors Aren't Entirely Convinced By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Earnings

Jan 15
Investors Aren't Entirely Convinced By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Earnings

These 4 Measures Indicate That Chongqing Zhifei Biological Products (SZSE:300122) Is Using Debt Reasonably Well

Nov 26
These 4 Measures Indicate That Chongqing Zhifei Biological Products (SZSE:300122) Is Using Debt Reasonably Well

Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Sep 30
Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be

Sep 03
Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be

Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)

Aug 23
Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)

We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt

Jul 26
We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt

Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E

May 21
Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E

CEO

Lingfeng Jiang (44 yo)

less than a year

Tenure

CN¥1,360,000

Compensation

Mr. Lingfeng Jiang is President of Chongqing Zhifei Biological Products Co. Ltd. from September 20, 2024. Mr. Jiang is Non-Independent Director of Chongqing Zhifei Biological Products Co. Ltd.from 2009. M...

Leadership Team

NamePositionTenureCompensationOwnership
Lingfeng Jiang
Vice Chairman of the Board & Presidentless than a yearCN¥1.36m5.41%
CN¥ 2.5b
Zhen Jing Li
VP, CFO & Directorno dataCN¥1.40mno data
Zhijun Wang
Chief Engineer6.1yrsCN¥1.36mno data
Fei Qin
VP, Secretary of Board & Directorno dataCN¥1.36mno data
Yu Zhang
Vice presidentless than a yearCN¥1.20m0.000080%
CN¥ 37.5k
Zhang Jing
Vice President8.8yrsCN¥1.36mno data
Jie Shao
Vice Presidentless than a yearCN¥422.60kno data

0.7yrs

Average Tenure

42yo

Average Age

Experienced Management: 300122's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Lingfeng Jiang
Vice Chairman of the Board & President15.8yrsCN¥1.36m5.41%
CN¥ 2.5b
Zhen Jing Li
VP, CFO & Director9.8yrsCN¥1.40mno data
Fei Qin
VP, Secretary of Board & Director8.6yrsCN¥1.36mno data
Rensheng Jiang
Chairman of the Board15.8yrsCN¥1.08m48.44%
CN¥ 22.7b
Xinrong Zhang
Independent Directorless than a yearCN¥67.60kno data
Lin Yuan
Independent Director3.7yrsCN¥240.00kno data
Lin Du
Non-Independent Director8.1yrsCN¥1.60mno data
Shilong Yang
Non-Independent Director6.8yrsCN¥1.60mno data
Tao Gong
Independent Director3.7yrsCN¥240.00kno data
Wei Zhou
Supervisorless than a yearno datano data

7.4yrs

Average Tenure

57yo

Average Age

Experienced Board: 300122's board of directors are considered experienced (7.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 19:49
End of Day Share Price 2025/05/08 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chongqing Zhifei Biological Products Co., Ltd. is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xin ZhangAJ Securities Co., Ltd
Bo LiBofA Global Research
Yuanrui LiuChangjiang Securities Co. LTD.